I have forwarded comments on a vignette but have not heard the outcome of this. Should I continue in forwarding my proposal for the HTA Clinical Evaluation and Trials workstream?
Experts who comment on a vignette will receive a letter notifying them of the outcome of the topic. This will be received approximately six months after they forward their comments. The reason for this delay is that following consideration by the advisory panel, the topic will be discussed by the Prioritisation Strategy Group which reviews all topics considered by the four advisory panels after each round of meetings and makes the final decision as to which topics will be referred for commissioning. In the meantime, the HTA programme would welcome proposals for the Clinical Evaluation and Trials workstream. I have just been asked to comment on a vignette for a similar topic to a proposal I forwarded to the HTA Clinical Evaluation and Trials workstream which was rejected. There are a number of reasons for why a proposal for the HTA Clinical Evaluation and Trials workstream may be rejected. A proposal may have been recognised as being important, but was not considered to be as high a pri
I have forwarded comments on a vignette but have not heard the outcome of this. Should I continue in forwarding my proposal for the HTA Clinical Evaluation and Trials workstream?